MoneyWorks4Me

Dr Reddy's signs pact with R-Pharm of Russia

22 Dec 2010 Evaluate

Dr Reddy's Laboratories Ltd has entered into a licensing, technology transfer; manufacturing and marketing agreement with R-Pharm of Russia. The collaboration is in the area of high-technology and works on a profit-sharing model. It will entail licensing of manufacturing know-how of products by Dr Reddy's, local manufacturing of products in Russia, co-development of high technology products and knowledge sharing between both parties at regular intervals.crackcrack

Dr. Reddys Labs. Share Price

1198.95 -6.05 (-0.50%)
12-Aug-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.00
Dr. Reddys Labs. 1198.95
Cipla 1461.55
Lupin 2264.70
Zydus Lifesciences 1204.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: